Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FAF1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | MANBAL | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |
mRNA | RP11-295K3.1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | CCAR2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | SNRPD3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
mRNA | ENTPD6 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | SUPT20H | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | MFRP | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | SPATA5L1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | RTF1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |